Showing results (1-10 of 207) with videos related to
Sort By:
Pageof 21
Trends in Biotechnology|December 10, 2014
Fc fusion as a platform technology: potential for modulating immunogenicityDitza Levin, Basil Golding, Scott E Strome, et al.Trends in Pharmacological Sciences|October 30, 2023
Emerging approaches to induce immune tolerance to therapeutic proteinsJustine C Noel, Daniel Lagassé, Basil Golding, et al.The AAPS Journal|May 8, 2019
Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their ImmunogenicityH A Daniel Lagassé, Hartmut Hengel, Basil Golding, et al.Frontiers in Immunology|April 24, 2024
Factor VIII moiety of recombinant Factor VIII Fc fusion protein impacts Fc effector function and CD16+ NK cell activationH A Daniel Lagassé, Jiayi Ou, Zuben E Sauna, et al.Plos One|March 3, 2012
Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteinsRan Zichel, Wanida Chearwae, Gouri Shankar Pandey, et al.Trends in Biotechnology|June 18, 2018
Evaluating and Mitigating the Immunogenicity of Therapeutic ProteinsZuben E Sauna, Daniel Lagassé, Joao Pedras-Vasconcelos, et al.The AAPS Journal|December 3, 2025
The Impact of Cognate Antigen Binding on the FcRn-mediated Transcytosis and Recycling of Monoclonal AntibodiesSharon Vijayanand, H A Daniel Lagasse, Million A Tegenge, et al.Biologicals : Journal of the International Association of Biological Standardization|January 14, 2012
Plasma derivatives: new products and new approachesZuben E Sauna, Gouri Shankar Pandey, Nisha Jain, et al.Frontiers in Immunology|July 15, 2021
Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16H A Daniel Lagassé, Louis B Hopkins, Wojciech Jankowski, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 11, 2014
Pharmacogenetics and the Immunogenicity of Protein TherapeuticsGouri S Pandey, Zuben E SaunaPageof 21